Trichomegaly following treatment with interferon alpha-2b.
Hernández-Núñez
Almudena
A
Department of Dermatology, Hospital Universitario de la Princesa, 28006, Madrid, Spain.
Fernández-Herrera
Jesús
J
Buceta
Luis Ríos
LR
García-Díez
Amaro
A
D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects*; D005140:Eyelashes / Q000187:drug effects / Q000254:growth & development*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D008297:Male; D011994:Recombinant Proteins
D000970:Antineoplastic Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins